All Lung Microbiome articles
-
NewsResearch team awarded NIH grant to study early immune determinants of human tuberculosis infection
A research team was awarded a 5-year, $3.8 million grant to study early immune responses in the lung and how they influence tuberculosis infection outcomes. The program focuses on how lung immune cells called macrophages influence the earliest stages of tuberculosis infection.
-
NewsAntibiotic proves ineffective in treating wheezing in young children in the emergency room
A study has shown that giving the antibiotic azithromycin did not help preschool children seen in the hospital emergency room with bouts of severe wheezing. It provides more definitive answers to longstanding questions and inconclusive studies about the role of some types of bacteria in wheezing and asthma.
-
NewsResearchers find increased bacteria infection in patients with chronic lung disease
A new study has found that people with bronchiectasis and chronic sinus disease were more likely to have mucus samples that tested positive for Pseudomonas aeruginosa. It suggests that doctors caring for patients with bronchiectasis may need to pay closer attention to sinus disease and bacterial testing.
-
NewsWhat the Andes hantavirus outbreak reveals about pandemic risk
The outbreak of Andes hantavirus aboard the international MV Hondius cruise ship underscores how little scientists still know about the viruses circulating silently in wild rodent populations before they spill into humans.
-
NewsGut microbiota impacts resistance to bacterial pneumonia: Study
A gut-lung connection influences susceptibility to infection by Acinetobacter baumannii, according to a new study. Investigators found that antibiotics disrupt the gut microbiota, suppress protective immune system pathways in the lungs; and increase the severity of pneumonia.
-
NewsAmbient air pollution is associated with respiratory infection burden in the first year of life
Ambient air pollution is associated with respiratory infection burden in the first year of life, according to preliminary findings from the Immune Development in Early Life (IDEaL) Rome Cohort.
-
NewsResearchers explore potential link between COVID-19 and lung cancer risk
New findings have identified a potential association between COVID-19 and increased lung cancer risk, driven by underlying biological mechanisms in the lung. The study integrates human clinical data with mechanistic research in animal and cellular models.
-
NewsCharacteristics of CD4+T-cell reduction and pulmonary infections in critically ill immunocompromised patients
A new study investigates the relationship between reduced CD4+T-cell counts and lung infections in immunosuppressed patients admitted to intensive care units (ICUs).
-
NewsBoth diseased and healthy lungs contain genes associated with antibiotic resistance
Researchers examined patients with COPD, asthma, pulmonary fibrosis (IPF), and sarcoidosis, and compared them with healthy individuals. The results show that antibiotic resistance genes were present in all groups.
-
NewsMicrobial warfare helps bacteria evolve, study shows
A study of commensal bacgteria shows that Streptococcus mitis can kill the pathogen Streptococcus pneumoniae during a physiological state known as competence, when bacteria become able to take up DNA from their surroundings.
-
NewsInappropriate antibiotic use for COVID-19 is linked to resistance
Taking azithromycin for as little as one day triggers antibiotic resistance in the respiratory tract, according to a first-of-its kind look by scientists at the changes that occur in the microbiome of hospitalized patients who were treated for COVID-19.
-
NewsSevere COVID-19 and flu facilitate lung cancer months or years later, new research shows
Severe COVID-19 and influenza infections prime the lungs for cancer and can accelerate the disease’s development, but vaccination heads off those harmful effects, new research indicates.
-
NewsHow microbes protect the lungs against allergies
A study has revealed that microbes protect the lungs from subsequently developing allergies and asthma. This long-term protection is “memorized” not by immune system cells but by fibroblasts, structural cells in the lungs.
-
NewsTargeting the gut–lung microbiome to reduce infections in severe pancreatitis
Researchers report new clinical evidence that a fungal probiotic may reduce hospital-acquired infections in patients with severe acute pancreatitis. Patients receiving Saccharomyces boulardii alongside standard enteral nutrition experienced significantly fewer infections than those receiving nutrition alone.
-
NewsStudy reveals key differences in long-term brain effects of COVID-19 and flu
While both Covid and flu can leave lasting lung damage, only SARS-CoV-2 infection caused persistent brain inflammation and small blood vessel injury, even after the virus was no longer detectable, a new study has found.
-
NewsHoly Grail: One vaccine may provide broad protection against many respiratory infections and allergens
In a new study in mice, researchers have developed a universal vaccine formula that protects against a wide range of respiratory viruses, bacteria and even allergens.
-
NewsEthris and German Center for Infection Research (DZIF) announce strategic collaboration to develop mRNA-based vaccines
Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and the German Center for Infection Research (DZIF), have announced a strategic research collaboration to develop mRNA-based vaccines for the prevention and treatment of infectious diseases.
-
NewsBreath carries clues to gut microbiome health
Researchers have shown that disease-associated bacteria in the gut can be detected through exhaled breath. They found that chemicals released by gut microbes and captured from the breath of children and mice can reveal the composition of the bacteria living in the intestines.
-
NewsLow vitamin D levels shown to raise risk of hospitalization with potentially fatal respiratory tract infections by 33%
Severe vitamin D deficiency is associated with a higher rate of hospitalisation for respiratory tract infections such as bronchitis and pneumonia. Scientists found that those with a severe deficiency (below 15 nnmol/L) were 33 per cent more likely to be admitted to hospital for treatment.
-
NewsResearchers discover how a respiratory bacterium obtains essential lipids from the human body and targets fat-rich tissues
A multidisciplinary team has uncovered a key mechanism that allows the human bacterium Mycoplasma pneumoniae—responsible for atypical pneumonia and other respiratory infections—to obtain cholesterol and other essential lipids directly from the human body.